Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Liang, Huiying ^a,b   Yang, Xuexi ^a   Chen, Lujia ^a   Li, Hong ^a   Zhu, Anna ^a   Sun, Minying ^c   Wang, Haitao ^b   Li, Ming ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangzhou Women and Children Medical Center   (China)

^c GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CODOMINANCE; CONTROLLED STUDY; EPIDERMAL GROWTH FACTOR RECEPTOR 2 BREAST CANCER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HOMOZYGOTE; HUMAN; INTRON; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MAJOR CLINICAL STUDY; MIDDLE AGED; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE NEGATIVE BREAST CANCER; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; CASE CONTROL STUDY; ETHNIC GROUP; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RISK FACTORS;

EID: 84941687059     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/626948     Document Type: Article

References (42)

1. D. F. Easton, K. A. Pooley, A. M. Dunning et al., "Genome-wide association study identifies novel breast cancer susceptibility loci," Nature, vol. 447, no. 7148, pp. 1087-1093, 2007.
2. B. Gold, T. Kirchhoff, S. Stefanov et al., "Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4340-4345, 2008.
3. D. J. Hunter, P. Kraft, K. B. Jacobs et al., "A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer,"NatureGenetics, vol. 39, no. 7, pp. 870-874, 2007.
4. S.N. Stacey,A.Manolescu,P.Sulemet al., "Commonvariantson chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer," Nature Genetics, vol. 39, no. 7, pp. 865-869, 2007.
5. S. N. Stacey, A. Manolescu, P. Sulem et al., "Common variants on chromosome 5p12 confer susceptibility to estrogen receptorpositive breast cancer," Nature Genetics, vol. 40, no. 6, pp. 703-706, 2008.
6. W. Zheng, J. Long, Y.-T. Gao et al., "Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1," Nature Genetics, vol. 41, no. 3, pp. 324-328, 2009.
7. J. Shan, W. Mahfoudh, S. P. Dsouza et al., "Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians," Breast Cancer Research and Treatment, vol. 135, no. 3, pp. 715-724, 2012.
8. M. Garcia-Closas, F. J. Couch, S. Lindstrom et al., "Genomewide association studies identify four ER negative-specific breast cancer risk loci," Nature Genetics, vol. 45, no. 4, pp. 392-398, 2013.
9. W. Han, J. H. Woo, J.-H. Yu et al., "Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype," Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 5, pp. 793-798, 2011.
10. M. S. Udler, K. B. Meyer, K. A. Pooley et al., "FGFR2 variants and breast cancer risk: fine-scalemapping using African American studies and analysis of chromatin conformation," Human Molecular Genetics, vol. 18, no. 9, pp. 1692-1703, 2009.
11. T. Sørlie, C. M. Perou, R. Tibshirani et al., "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications," Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 98,no. 19,pp. 10869-10874, 2001.
12. C. M. Perou, T. Sørile,M. B. Eisen et al., "Molecular portraits of human breast tumours," Nature, vol. 406, no. 6797, pp. 747-752, 2000.
13. M. Chan, S. M. Ji, C. S. Liaw et al., "Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population," Breast Cancer Research and Treatment, vol. 136, no. 1, pp. 209-220, 2012.
14. D. Campa, M. Barrdahl, K. K. Tsilidis et al., "A genome-wide 'pleiotropy scan' does not identify new susceptibility loci for estrogen receptor negative breast cancer," PLoS ONE, vol. 9, no. 2, Article ID e85955, 2014.
15. J. R. Palmer, E. A. Ruiz-Narvaez, C. N. Rotimi et al., "Genetic susceptibility loci for subtypes of breast cancer in an African American population," Cancer Epidemiology Biomarkers and Prevention, vol. 22, no. 1, pp. 127-134, 2013.
16. M. Garcia-Closas, P. Hall, H. Nevanlinna et al., "Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics," PLoS Genetics, vol. 4, no. 4, Article ID e1000054, 2008.
17. M. Garcia-Closas and S. Chanock, "Genetic susceptibility loci for breast cancer by estrogen receptor status," Clinical Cancer Research, vol. 14, no. 24, pp. 8000-8009, 2008.
18. X. He, G. Yao, F. Li, M. Li, and X. Yang, "Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China," International Journal of Molecular Sciences, vol. 15, no. 2, pp. 2130-2141, 2014.
19. M. Sun, X. Yang, C. Ye et al., "Risk-association of CYP11A1 polymorphisms and breast cancer among han Chinese women in Southern China," International Journal ofMolecular Sciences, vol. 13, no. 4, pp. 4896-4905, 2012.
20. Q. Pan, Y. Ning, L. Z. Chen et al., "Association of MHC class-III gene polymorphisms with ER-positive breast cancer in Chinese Han population.," Genetics and Molecular Research, vol. 11, no. 4, pp. 4299-4306, 2012.
21. L.Tong, X.-X.Yang, M.-F. Liu et al., "Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients," Asian Pacific Journal of Cancer Prevention, vol. 13, no. 11, pp. 5599-5603, 2012.
22. J. M. Ramon, J. Escribal, I. Casas et al., "Age at first full-term pregnancy, lactation and parity and risk of breast cancer: a casecontrol study in Spain," European Journal of Epidemiology, vol. 12, no. 5, pp. 449-453, 1996.
23. H. Ma, J. Luo, M. F. Press, Y. Wang, L. Bernstein, and G. Ursin, "Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer," Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 2, pp. 479-485, 2009.
24. L. S. Dominici, E. A. Mittendorf, X. Wang et al., "Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy," Breast Cancer Research, vol. 14, no. 3, article R82, 2012.
25. B.Keam, S.-A. Im,K.-H. Lee et al., "Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis," Breast Cancer Research, vol. 13, article R22, 2011.
26. X. Solé, E. Guinó, J. Valls, R. Iniesta, and V.Moreno, "SNPStats: aweb tool for the analysis of association studies," Bioinformatics, vol. 22, no. 15, pp. 1928-1929, 2006.
27. J.Wesche, K. Haglund, and E. M. Haugsten, "Fibroblast growth factors and their receptors in cancer," Biochemical Journal, vol. 437, no. 2, pp. 199-213, 2011.
28. K. B. Meyer, A.-T. Maia, M. O'Reilly et al., "Allele-specific upregulation of FGFR2 increases susceptibility to breast cancer," PLoS Biology, vol. 6, no. 5, article e108, 2008.
29. J. Liang, P. Chen, Z. Hu et al., "Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women," Carcinogenesis, vol. 29, no. 12, pp. 2341-2346, 2008.
30. W. Zheng, W. Wen, Y.-T. Gao et al., "Genetic and clinical predictors for breast cancer risk assessment and stratification among chinesewomen," Journal of theNational Cancer Institute, vol. 102, no. 13, pp. 972-981, 2010.
31. J. Long, X.-O. Shu, Q. Cai et al., "Evaluation of breast cancer susceptibility loci in Chinese women," Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 9, pp. 2357-2365, 2010.
32. F. Chen, M. Lv, Y. Xue et al., "Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of theHan nationality," Immunogenetics, vol. 64, no. 1, pp. 71-76, 2012.
33. L. Raskin, M. Pinchev, C. Arad et al., "FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations," Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 5, pp. 1060-1065, 2008.
34. F. Fu, C. Wang, M. Huang, C. Song, S. Lin, and H. Huang, "Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women," Tohoku Journal of Experimental Medicine, vol. 226, no. 3, pp. 221-229, 2012.
35. Y. Sapkota, Y. Yasui, R. Lai et al., "Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm," PLoS ONE, vol. 8, no. 5,Article ID e62550, 2013.
36. A. Broeks, M. K. Schmidt, M. E. Sherman et al., "Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings fromthe Breast Cancer Association Consortium," Human Molecular Genetics, vol. 20, no. 16, pp. 3289-3303, 2011.
37. Y. A. Luqmani, M. Graham, and R. C. Coombes, "Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues," British Journal of Cancer, vol. 66, no. 2, pp. 273-280, 1992.
38. S. Siddiqui, S. Chattopadhyay, M. S. Akhtar et al., "A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of Breast cancer fromNorth India," PLoS ONE, vol. 9, no. 10,Article ID e110426, 2014.
39. S. H. Nordgard, F. E. Johansen, G. I. G. Alnæs, B. Naume, A.-L. Børresen-Dale, and V. N. Kristensen, "Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes," Breast Cancer Research, vol. 9, no. 6, article 113, 2007.
40. G. A. Colditz, B. A. Rosner, W. Y. Chen, M. D. Holmes, and S. E. Hankinson, "Risk factors for breast cancer according to estrogen and progesterone receptor status," Journal of the National Cancer Institute, vol. 96, no. 3, pp. 218-228, 2004.
41. H. Ma, L. Bernstein, M. C. Pike, and G. Ursin, "Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: ameta-analysis of epidemiological studies," Breast Cancer Research, vol. 8, no. 4, article R43, 2006.
42. J. J. de Ronde, J. Hannemann, H. Halfwerk et al., "Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response," Breast Cancer Research and Treatment, vol. 119, no. 1, pp. 119-126, 2010.